We've found
17,797
archived clinical trials in
Peripheral Vascular Disease
We've found
17,797
archived clinical trials in
Peripheral Vascular Disease
Deferoxamine to Prevent Delayed Cerebral Ischemia After Subarachnoid Hemorrhage
Updated: 7/17/2015
Deferoxamine: An Emerging Therapy to Prevent Delayed Cerebral Ischemia After Subarachnoid Hemorrhage
Status: Enrolling
Updated: 7/17/2015
Deferoxamine to Prevent Delayed Cerebral Ischemia After Subarachnoid Hemorrhage
Updated: 7/17/2015
Deferoxamine: An Emerging Therapy to Prevent Delayed Cerebral Ischemia After Subarachnoid Hemorrhage
Status: Enrolling
Updated: 7/17/2015
Click here to add this to my saved trials
Erythropoetin Neuroprotection for Neonatal Cardiac Surgery
Updated: 7/20/2015
Erythropoetin Neuroprotection for Neonatal Cardiac Surgery
Status: Enrolling
Updated: 7/20/2015
Erythropoetin Neuroprotection for Neonatal Cardiac Surgery
Updated: 7/20/2015
Erythropoetin Neuroprotection for Neonatal Cardiac Surgery
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
TAXUS Libertē Post Approval Study
Updated: 7/20/2015
TAXUS Libertē Post Approval Study: A U.S. Post-Approval Study of the TAXUS® Liberté® Paclitaxel-Eluting Coronary Stent System
Status: Enrolling
Updated: 7/20/2015
Click here to add this to my saved trials